OxyContin maker Purdue Pharma reportedly exploring bankruptcy

इंडिया समाचार समाचार

OxyContin maker Purdue Pharma reportedly exploring bankruptcy
इंडिया ताज़ा खबर,इंडिया मुख्य बातें
  • 📰 NBCNews
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 86%

OxyContin maker Purdue Pharma is exploring filing for bankruptcy to address potentially significant liabilities from thousands of lawsuits, Reuters reports citing people familiar with the matter.

OxyContin maker Purdue Pharma is exploring filing for bankruptcy to address potentially significant liabilities from thousands of lawsuits alleging the drug manufacturer contributed to the deadly opioid crisis sweeping the United States, people familiar with the matter said on Monday.

Purdue denies the allegations, arguing that the U.S. Food and Drug Administration-approved labels for its opioids carried warnings about the risk of abuse and misuse associated with the drugs. More than 1,000 lawsuits accusing Purdue and other opioid manufacturers of using deceptive practices to push addictive drugs that led to fatal overdoses are consolidated in an Ohio federal court. Purdue has held discussions to resolve the litigation with plaintiffs' lawyers who have often compared the cases to widespread lawsuits against the tobacco industry that resulted in a $246 billion settlement in 1998.

"As a privately held company, it has been Purdue Pharma’s longstanding policy not to comment on our financial or legal strategy," Purdue said in a statement.

हमने इस समाचार को संक्षेप में प्रस्तुत किया है ताकि आप इसे तुरंत पढ़ सकें। यदि आप समाचार में रुचि रखते हैं, तो आप पूरा पाठ यहां पढ़ सकते हैं। और पढो:

NBCNews /  🏆 10. in US

इंडिया ताज़ा खबर, इंडिया मुख्य बातें

Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।

Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesExclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesOxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address p...
और पढो »

Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesExclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesThe deliberations show how Purdue and its wealthy owners, the Sackler family, are under pressure to respond to mounting litigation accusing the pharmaceutical company of misleading doctors and patients about risks associated with prolonged use of its prescription opioids. Purdue denies the allegations
और पढो »

Purdue Pharma says opioid lawsuit by Mass. attorney general amounts to ‘oversimplified scapegoating’Purdue Pharma says opioid lawsuit by Mass. attorney general amounts to ‘oversimplified scapegoating’The suit alleges that Purdue disregarded safety and pushed doctors to prescribe high doses of OxyContin.
और पढो »

Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesExclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesOxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address p...
और पढो »

Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesExclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesThe deliberations show how Purdue and its wealthy owners, the Sackler family, are under pressure to respond to mounting litigation accusing the pharmaceutical company of misleading doctors and patients about risks associated with prolonged use of its prescription opioids. Purdue denies the allegations
और पढो »

Purdue Pharma says opioid lawsuit by Mass. attorney general amounts to ‘oversimplified scapegoating’Purdue Pharma says opioid lawsuit by Mass. attorney general amounts to ‘oversimplified scapegoating’The suit alleges that Purdue disregarded safety and pushed doctors to prescribe high doses of OxyContin.
और पढो »

Opinion | The OxyContin catastrophe highlights a big failure in policyA Massachusetts lawsuit accuses Sackler family members of “illegal deceit” in the promotion of the opioid.
और पढो »

Aurora Cannabis to acquire 51% stake in Portugal's Gaia Pharma, set up medical cannabis facility
और पढो »

These Senators Received The Biggest Checks From Pharma Companies Testifying TuesdaySeven pharma executives are expected to face tough questions about the price of their drugs Tuesday before the U.S. Senate Finance Committee. They’ll also be answering to a group that’s received hundreds of thousands of dollars in campaign contributions from their own companies’ PACs.
और पढो »



Render Time: 2025-02-28 14:41:22